EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A trans -translation inhibitor that targets ribosomal protein bL12 kills Mycobacterium tuberculosis

Akanksha Varshney iD, John N Alumasa, Amber Miller, Kenneth C Keiler iD

Journal of Bacteriology · 2025

DOI: 10.1128/jb.00236-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bacteriology, 2025. Verfasst von Akanksha Varshney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Ribosomal Proteins, Bacterial Proteins, Antitubercular Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New antibiotics with novel mechanisms of action are needed to treat infections by multidrug-resistant strains of Mycobacterium tuberculosis . Here, we show that KKL-1005, an anti-tubercular triazole-based molecule, binds to ribosomal protein bL12 and specifically inhibits the trans -translation ribosome rescue pathway, a process essential for the survival of M. tuberculosis . Our data demonstrate that KKL-1005 binds to the N-terminal domain of bL12, both in vitro and in bacterial cells, and specifically inhibits trans -translation and not normal translation. These results suggest that tmRNA-SmpB interacts with bL12 differently from tRNA and raise the possibility of developing antibiotics targeting bL12. IMPORTANCE Tuberculosis continues to be a leading cause of death worldwide, and antibiotics that target new pathways are urgently needed. trans -Translation is a ribosome rescue pathway required for the survival of Mycobacterium tuberculosis . We identified a small molecule, KKL-1005, that specifically inhibits trans -translation without affecting translation from a library of compounds that prevent the growth of M. tuberculosis . KKL-1005 targets bacterial ribosomal protein bL12, which is essential for the recruitment and activation of GTPase translation factors. The specificity of KKL-1005 for trans -translation indicates that bL12 interacts differently with the translation machinery during trans -translation than during canonical translation. KKL-1005 is bactericidal against M. tuberculosis , suggesting that inhibiting trans -translation by targeting bL12 is a new strategy for developing antibiotics against drug-resistant infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisRibosomal ProteinsBacterial ProteinsAntitubercular AgentsProtein BiosynthesisTriazolesRibosomesMicrobial Sensitivity TestsProtein Binding

Stichwörter der Autor:innen

Mycobacterium tuberculosisbL12ribosometmRNAtrans-translation

Substanzen

Ribosomal ProteinsBacterial ProteinsAntitubercular AgentsTriazoles

Autor:innen und Institutionen

  • Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
  • Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania, USA.

ORCID-Profile: Akanksha Varshney, Kenneth C Keiler

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Varshney, A., Alumasa, J. N., Miller, A., & Keiler, K. C. (2025). A trans -translation inhibitor that targets ribosomal protein bL12 kills Mycobacterium tuberculosis. Journal of Bacteriology. https://doi.org/10.1128/jb.00236-25

Vancouver

Varshney A, Alumasa JN, Miller A, Keiler KC. A trans -translation inhibitor that targets ribosomal protein bL12 kills Mycobacterium tuberculosis. Journal of Bacteriology. 2025. doi:10.1128/jb.00236-25

BibTeX
@article{Varshney2025,
  author = {Varshney, Akanksha and Alumasa, John N and Miller, Amber and Keiler, Kenneth C},
  title = {A trans -translation inhibitor that targets ribosomal protein bL12 kills Mycobacterium tuberculosis},
  journal = {Journal of Bacteriology},
  year = {2025},
  doi = {10.1128/jb.00236-25}
}
Kostenlos starten →